Related references
Note: Only part of the references are listed.De novo Therapy with Everolimus, Low-Dose Ciclosporine A, Basiliximab and Steroid Elimination in Pediatric Kidney Transplantation
L. Pape et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2010)
Human cytomegalovirus-specific CD4+ and CD8+ T-cell response determination: Comparison of short-term (24 h) assays vs long-term (7-day) infected dendritic cell assay in the immunocompetent and the immunocompromised host
Paola Zelini et al.
CLINICAL IMMUNOLOGY (2010)
Evaluation of Cytomegalovirus (CMV)-Specific T Cell Immune Reconstitution Revealed That Baseline Antiviral Immunity, Prophylaxis, or Preemptive Therapy but not Antithymocyte Globulin Treatment Contribute to CMV-Specific T Cell Reconstitution in Kidney Transplant Recipients
Davide Abate et al.
JOURNAL OF INFECTIOUS DISEASES (2010)
Lower incidence of cytomegalovirus infection with everolimus versus mycophenolate mofetil in de novo cardiac transplant recipients: a randomized, multicenter study
M. Vigano et al.
TRANSPLANT INFECTIOUS DISEASE (2010)
International Consensus Guidelines on the Management of Cytomegalovirus in Solid Organ Transplantation
Camille N. Kotton et al.
TRANSPLANTATION (2010)
Preemptive Therapy for Systemic and Pulmonary Human Cytomegalovirus Infection in Lung Transplant Recipients
G. Gerna et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2009)
A lower incidence of cytomegalovirus infection in de novo heart transplant recipients randomized to everolimus
James A. Hill et al.
TRANSPLANTATION (2007)
Evaluation of intervention strategy based on CMV-specific immune responses after allogeneic SCT
G. Avetisyan et al.
BONE MARROW TRANSPLANTATION (2007)
Inconsistent responses of cytomegalovirus-specific T cells to pp65 and IE-1 versus infected dendritic cells in organ transplant recipients
D. Lilleri et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2007)
Relationship between cytomegalovirus DNA load in epithelial lining fluid and plasma of lung transplant recipients and analysis of coinfection with Epstein-Barr virus and human herpesvirus 6 in the lung compartment
Claudia C. Bauer et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2007)
Monitoring of human cytomegalovirus-specific CD4+ and CD8+ T-cell immunity in patients receiving solid organ transplantation
G. Gerna et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2006)
Impact of human metapneumovirus and human cytomegalovirus versus other respiratory viruses on the lower respiratory tract infections of lung transplant recipients
G Gerna et al.
JOURNAL OF MEDICAL VIROLOGY (2006)
Differences in CMV-specific T-cell levels and long-term susceptibility to CMV infection after kidney, heart and lung transplantation
U Sester et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2005)
Simultaneous quantification of human cytomegalovirus (HCMV)-specific CD4+ and CD8+ T cells by a novel method using monocyte-derived HCMV-infected immature dendritic cells
L Lozza et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2005)
Clinical utility of cytomegalovirus viral load in bronchoalveolar lavage in lung transplant recipients
RF Chemaly et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2005)
Clinical and immunologic aspects of cytomegalovirus infection in solid organ transplant recipients
AT Rowshani et al.
TRANSPLANTATION (2005)
Dendritic-cell infection by human cytomegalovirus is restricted to strains carrying functional UL131-128 genes and mediates efficient viral antigen presentation to CD8+ T cells
G Gerna et al.
JOURNAL OF GENERAL VIROLOGY (2005)
Cellular immune responses to cytomegalovirus in renal transplant recipients
R Radha et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2005)
Human cytomegalovirus load in plasma and bronchoalveolar lavage fluid: A longitudinal study of lung transplant recipients
GP Westall et al.
JOURNAL OF INFECTIOUS DISEASES (2004)
Clinically-Based determination of safe DNAemia cutoff levels for preemptive therapy or human cytomegalovirus infections in solid organ and hematopoietic stem cell transplant recipients
D Lilleri et al.
JOURNAL OF MEDICAL VIROLOGY (2004)
Primary immune responses to human CMV:: a critical role for IFN-γ-producing CD4+ T cells in protection against CMV disease
LE Gamadia et al.
BLOOD (2003)
Dominance of virus-specific CD8 T cells in human primary cytomegalovirus infection
M Sester et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2002)
Sensitive detection of human cytomegalovirus peptide-specific cytotoxic T-lymphocyte responses by interferon-γ-enzyme-linked immunospot assay and flow cytometry in healthy individuals and in patients after allogeneic stem cell transplantation
H Hebart et al.
BLOOD (2002)
Definitions of cytomegalovirus infection and disease in transplant recipients
P Ljungman et al.
CLINICAL INFECTIOUS DISEASES (2002)
Tetramer-based quantification of cytomegalovirus (CMV)-specific CD8+ T lymphocytes in T-cell-depleted stem cell grafts and after transplantation may identify patients at risk for progressive CMV infection
JW Gratama et al.
BLOOD (2001)
Differentiation of cytomegalovirus-specific CD8+ T cells in healthy and immunosuppressed virus carriers
LE Gamadia et al.
BLOOD (2001)
Levels of virus-specific CD4 T cells correlate with cytomegalovirus control and predict virus-induced disease after renal transplantation
M Sester et al.
TRANSPLANTATION (2001)
Quantification of cytomegalovirus DNA in BAL fluid -: A longitudinal study in lung transplant recipients
GC Riise et al.
CHEST (2000)
Development of virus-specific CD4+ T cells during primary cytomegalovirus infection
RJ Rentenaar et al.
JOURNAL OF CLINICAL INVESTIGATION (2000)
Share Paper
